Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Molina Healthcare, Inc. filings document the regulatory record for a managed healthcare company serving Medicaid, Medicare and state insurance marketplace programs. Its 8-K reports disclose operating results, premium revenue and earnings guidance, Regulation FD investor presentations, material agreements, direct financial obligations, impairment charges and senior unsecured note financing.
The company's proxy and governance filings cover annual meeting proposals, director and executive compensation matters, equity incentive plan authorization and amendments to charter or bylaw provisions such as stockholder special-meeting rights. The filing record also describes capital-structure terms, credit agreement covenants, risk-factor references and shareholder voting outcomes.
Molina Healthcare Chief Accounting Officer Maurice Hebert sold 600 shares of common stock in an open-market transaction at $191.55 per share. After the sale, he directly holds 12,815 shares. Footnotes indicate additional restricted shares are scheduled to vest in 2027, 2028, and 2029, with remaining awards already vested.
Molina Healthcare, Inc. ownership disclosure: AQR Capital Management, LLC and its parent AQR Capital Management Holdings, LLC report beneficial ownership of 2,863,393 shares of Molina Healthcare common stock, representing 5.50% of the class.
The filing shows shared voting power of 2,751,746 shares and indicates AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow reported an open-market sale of 17,811 shares of common stock on May 11, 2026. The shares were sold at a volume-weighted average price of $186.12 per share, with individual trade prices ranging from $186.01 to $186.86. After this transaction, Barlow directly holds 67,175 shares of Molina Healthcare common stock. A related equity award is scheduled to vest in tranches of 7,296 shares on March 1, 2027, 6,193 shares on March 1, 2028, and 4,574 shares on March 1, 2029, with the remaining award already vested.
Morgan Stanley Smith Barney LLC filed a Form 144 notice for proposed sales of Common Stock. The filing lists multiple blocks of restricted stock and performance shares with individual lot counts shown (for example, 1,176; 810; 9,373; 1,064; 3,661; 1,727). The filing shows 05/11/2026 and NYSE as the exchange.
Molina Healthcare, Inc. reported results from its May 6, 2026 annual stockholder meeting. Stockholders approved an amendment to the 2025 Equity Incentive Plan, increasing the shares of common stock authorized for issuance by 1,500,000 shares to a total of 3,295,000 shares.
Investors also approved an amendment to the Certificate of Incorporation and related bylaw changes that allow stockholders holding at least 20% of the voting power, and meeting specified ownership and disclosure requirements, to request special meetings, subject to several limitations on repeat or overlapping agenda items.
All ten director nominees were elected and all five proposals passed, including advisory approval of named executive officer compensation and ratification of Ernst & Young LLP as independent auditor. The meeting had strong participation, with 47,172,628 shares represented, or 90.55% of the 52,091,073 shares outstanding as of the record date.
SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.
Molina Healthcare, Inc. director Francis S. Soistman Jr. received a grant of 170 shares of common stock on May 6, 2026 under the company’s 2025 Incentive Plan, as a prorated quarterly director award. The grant was valued at the closing price of $197.44 per share on that date, and following this award he directly holds 670 shares of Molina Healthcare common stock.
Molina Healthcare, Inc. filed a current report stating it is hosting an Investor Day conference on May 8, 2026, beginning at 9:30 a.m. Eastern Time. During the event, the company plans to share updates on its business, including long-term financial targets and strategic and operational plans.
The presentation used for Investor Day is provided as Exhibit 99.1 and is incorporated by reference. A live webcast and a 30-day online replay of the event will be available on the company’s investor relations website.
MOLINA HEALTHCARE, INC. director Francis S. Soistman Jr filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows he directly holds 500 shares of Common Stock. This is a holdings-only report with no reported purchases, sales, or derivative positions.
Molina Healthcare Inc reports that Vanguard Capital Management beneficially owns 2,704,951 shares of Common Stock as of 03/31/2026. That stake represents 5.19% of the class; Vanguard reports sole voting power for 394,721 shares and sole dispositive power for 2,704,951 shares. The filing notes that dispositive and voting power is exercised by Vanguard Capital Management LLC and affiliated Vanguard business divisions.